Financials
- Market Capitalization 388.56 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.1
Rapporto prezzo/fatturato
146.28
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2861 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.19 USD | -2.39% | -10.06% | +7.15% | -40.23% | 551.67 M USD | ||
| 3046 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.31 USD | -2.42% | -9.78% | -15.65% | +29.64% | 422.13 M USD | ||
| 3302 | QTTB Q32 Bio Inc. - Common Stock | 18.46 USD | -13.66% | +37.15% | +43.77% | +783.25% | 313.02 M USD | ||
| 3339 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.37 USD | -2.24% | -7.23% | -6.69% | -7.65% | 301.33 M USD |